Ablynx: HY 2015 Results (Ablynx) - Aug 29, 2015 - Anticipated completion of enrollment of 558 patients from monotherapy P2b study (NCT02287922) and combination P2b study (NCT02309359) for RA by early 2016
Anticipated enrollment status • Immunology • Rheumatoid Arthritis
|